HIV/AIDS epidemiology in Poland. Late presentation of HIV infection & AIDS



Similar documents
GARPR Online Reporting Tool

Syphilis on the rise again in Germany results from surveillance data for 2011

Estimates of New HIV Infections in the United States

HIV Continuum of Care Monitoring Framework 2014

HIV and Hepatitis Co-infection. Martin Fisher Brighton and Sussex University Hospitals, UK

Global Update on HIV Treatment 2013: Results, Impact and Opportunities

Epidemiology of HCV and HIV/HCV Infection in Guangzhou, China. Title. Charles Wang, M.D.

THIS IS AN OFFICIAL NH DHHS HEALTH ALERT

4/3/2012. Surveillance. Direct Care. Prevention. Quality Management

Placing Nation on the Path Toward the Elimination of Hepatitis C

Dual elimination of mother-to-child transmission (MTCT) of HIV and syphilis

Poor access to HCV treatment is undermining Universal Access A briefing note to the UNITAID Board

New Brunswick Health Indicators

Epidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid

Outpatient/Ambulatory Health Services

Meena Abraham, DrPH, MPH Director of Epidemiology Services Baltimore City Health Department

Case Finding for Hepatitis B and Hepatitis C

HIV/AIDS Epidemic Status at-a-glance

Potential impact of routine testing of patients with HIV indicator disease in preventing late HIV diagnosis

HIV New Diagnoses, Treatment and Care in the UK 2015 report

Increase of sexually transmitted hepatitis C virus in HIV+ men who have sex with men in Barcelona, Spain. A problem linked to HIV infection?

Update January Quick Start Guide for Spectrum

HIV/AIDS: General Information & Testing in the Emergency Department

Rhode Island Department of Health Division of Infectious Diseases and Epidemiology

Routine HIV Monitoring

Aim of Presentation. The Role of the Nurse in HIV Care. Global Epidemic 7/24/09

DC Comprehensive HIV Prevention Plan for : Goals and Objectives

Using Substance Abuse Prevention and Treatment (SAPT) Block Grant HIV Set- Aside Funds for Integrated Services

HPTN 073: Black MSM Open-Label PrEP Demonstration Project

HEPATITIS WEB STUDY Acute Hepatitis C Virus Infection: Epidemiology, Clinical Features, and Diagnosis

Ethical Principles Regarding the Use of Assisted Reproduction in HIV Infected Individuals

Georgia HIV/AIDS Surveillance Summary. Data Through December 31, 2010

Recommended Ethical Principles. Regarding the Use of Assisted Reproduction. in HIV Infected Individuals

Evidence based Prevention & Treatment Options for Emerging Heroin Use in a Public Health Framework

Health Profile for St. Louis City

04/06/2015. Aaron V. Sapp, MD, MBA University of Missouri Columbia Student Health Center

UNITED NATIONS GENERAL ASSEMBLY SPECIAL SESSION ON HIV/AIDS. Country Progress Report Sweden

Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges

CME Article Hiv Disease Surveillance

The HIV/AIDS Epidemic in California s Latino Population

SIXTY-SEVENTH WORLD HEALTH ASSEMBLY. Agenda item May Hepatitis

FAQs HIV & AIDS. What is HIV? A virus that reduces the effectiveness of your immune system, meaning you are less protected against disease.

HIV Epidemiology in New York State

MS. ALINA POTRYKOWSKA

Hepatitis C Virus Infection in Massachusetts: A tale of two epidemics

Response to HIV/AIDS in Brazil, public health system strengthening and programmatic integration

João Silva de Mendonça, MD, PhD Infectious Diseases Service Hospital do Servidor Público Estadual São Paulo - Brazil

Screening and Treatment for Hepatitis C in HIV Co-Infected Patients in Primary Care

Q&A on methodology on HIV estimates

XVIIth International Aids Conference, Mexico City

HIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline

Injection Drug Use, HIV and HCV Infection in Ontario: The Evidence 1992 to 2004

Zika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases

Goal 6. Combat HIV/AIDS, malaria and other diseases

Richard H. Needle, PhD, MPH Lin Zhao, PhD candidate (UCSF School of Nursing) CSIS Africa Program Roundtable June 10, 2010

METHADONE SUBSTITUTION THERAPY PROGRAM AND TOXICOLOGICAL STUDIES

HIV/AIDS Prevention and Care

METHODOLOGICAL ISSUES IN THE MEASURES OF MATERNAL MORBIDITY MORTALITY (MM 1 MM 2 ) Dr. AKO Simon

AREAS OF FOCUS POLICY STATEMENTS

2004 Update. Lesotho

How To Get A Phd At The University Of Sydney

HIV Infection Among Those with an Injection Drug Use*-Associated Risk, Florida, 2014


Mother s blood test to check her unborn baby s blood group

In Tanzania, ARVs were introduced free-of-charge by the government in 2004 and, by July 2008, almost 170,000 people were receiving the drugs.

hiv/aids Programme Use of Antiretroviral Drugs for Treating Pregnant Women and Preventing HIV Infection in Infants

EPIDEMIOLOGY OF HEPATITIS B IN IRELAND

NICHD s Pediatric, Adolescent, & Maternal AIDS Branch

Frequently Asked Questions: Pre-Exposure Prophylaxis (PrEP) for HIV Infection Massachusetts Department of Public Health Updated July 2013

HIV/AIDS In the Houston Area

EVALUATION OF ACCESS TO HIV/AIDS TREATMENT AND CARE IN LATVIA

Drug Use and Abuse in San Diego County, California: 2013

Community Health Administration

HIV infection in injecting drug users

State of Louisiana Department of Health & Hospitals Office of Public Health

Seek and Treat for Optimal Prevention (STOP) of HIV Progress Report

Meeting Report Prevention and Treatment of HIV/AIDS among Drug Using Populations: A Global Perspective

HIV Pre-Exposure Prophylaxis (PrEP): A brief guide for providers updated January 2016

Hepatitis at a national level: government perspectives

Healthy People 2020: Who s Leading the Leading Health Indicators?

Coinfezione HIV-HCV. Raffaele Bruno, MD. Department of Infectious Diseases, University of Pavia Fondazione IRCCS Policlinico San Matteo, Pavia, Italy

Chapter 21. What Are HIV and AIDS?

Borderless Diseases By Sunny Thai

A Ministry of the Archdiocese of Galveston-Houston A United Way Agency

Lyme Disease in Pregnancy. Dr Sarah Chissell Consultant Obstetrician William Harvey Hospital, Kent

Program Performance Indicators Revised Baseline & Target Setting Form January 1 June 30, 2004 Interim Progress Report

PLUS MAY EQUAL. Flu-Like Symptoms SORE THROAT, SWOLLEN GLANDS, FEVER, JOINT AND MUSCLE ACHES

Draft Law on Public Health

HIV/AIDS in the Houston Area

EMERGING CLINICAL ISSUE: HEPATITIS C INFECTION IN HIV-INFECTED MEN WHO HAVE SEX WITH MEN

Doctor in Society (DIS) Stream

Sexual Health and Sexually Transmitted Infections Prevention and Control Protocol, 2013 (Revised)

Managing Bloodborne Pathogens Exposures

HIV Surveillance Update

Prevention Agenda is the state health improvement plan for the next five years.

Gonneke Hermanides, MD Izzy Gerstenbluth, MD epidemiologist

Resources for the Prevention and Treatment of Substance Use Disorders

Part 4 Burden of disease: DALYs

Annual Surveillance Report 2014 Supplement

Hepatitis C: Epidemiology, Transmission, and Screening. Jennifer Price, MD Assistant Professor of Medicine University of California San Francisco

Transcription:

HIV/AIDS epidemiology in Poland. Late presentation of HIV infection & AIDS Magdalena Leszczyszyn-Pynka Department of Infectious Diseases, Hepatology and Acquired Immunodeficiences Pomeranian Medical University in Szczecin Potsdam, 20.11. 2013

HIV i AIDS in Europie 1-2001 r. ~ 1,6 mln infected - 2011 r. ~ 2,3 mln infected - ~ 50% do not know about the infection - ~ 50% are co-infected with HCV 1 www.euro.who.int

FACTS 1. HIV pozwala dożyć średniej wieku swojej płci w swoim kraju 2. Zakażenie jest BEZOBJAWOWE przez średnio 10 lat 3. DIAGNOSIS of HIV infection in Europe in > 50% cases in pts with AIDS 4. globally HIV is the major cause of mortality among women of reproductive age and was responsible for the death of 280 000 children in 2008 1.Bhavan KP i wsp. Curr HIV/AIDS Rep 2008; 5: 150-8., 2. EACS 05, PE18.4/7, 3. Mack KA i wsp.jaids 2003 4. WHO HIV/AIDS Strategy for 2011-2015. 63 WHA, 21 May 2010, document UNAIDS/09.13E

Doświadczenia własne (Our own experiences) PONAD 50% NOWO WYKRYTYCH ZAKAŻEŃ HIV = DIAGNOZA AIDS Bander D. i wsp., PÓŹNE WYKRYWANIE AIDS MATERIALE WŁASNYM (2009, Przeg. Epidem.) W

Poland 31 Aug 2013 17 084 polish citizens confirmed HIV inf. 2948 AIDS cases (CDC/WHO def) 1220 AIDS deaths 25% - women, 75% - men ~ 35-40 % - HIV/HCV Source: Department of Epidemiology National Institute of Public Health National Institute of Hygiene (NIZP PZH) http://www.pzh.gov.pl/oldpage/epimeld/hiv_aids/index.htm

HIV cases, AIDS cases, AIDS deaths - 1996-2012 http://www.pzh.gov.pl/oldpage/epimeld/hiv_aids/index.htm

HIV in Poland new diagnosis 1.01.2013.-31.08.2013. 771 2012 1019 2011 1302 2010-1207 http://www.pzh.gov.pl/oldpage/epimeld/hiv_aids/index.htm

Annual HIV infections incidence - cases/100 000 citizens (mean for 2008-2012) We are here http://www.pzh.gov.pl/oldpage/epimeld/hiv_aids/index.htm

Annual AIDS cases incidence - cases/100 000 citizens (mean for 2008-2012) http://www.pzh.gov.pl/oldpage/epimeld/hiv_aids/index.htm

AIDS cases 2008-2012 route of the transmission??? MSM Ht sex IDUs http://www.pzh.gov.pl/oldpage/epimeld/hiv_aids/index.htm

wsse-poznan.pl Polska

Definitions 1. Late presentation: persons presenting for care with a CD4 count below 350 cells/µl or presenting with an AIDS-defining event, regardless of the CD4 cell count. 2. Presentation with advanced HIV disease: persons presenting for care with a CD4 count below 200 cells/µl or presenting with an AIDS-defining event, regardless of the CD4 cell count. Antinori A et al for the European Late Presenter Consensus working group, HIV Medicine (2010) DOI: 10.1111/j.1468-1293.2010.00857.x

HIV in Szczecin new patients 2011-2013* 2011 2012 (mean age) 2013 (till 19.11.13) % 50 + % LATE PRESEN- TERS DEATHS MEN 114 (34,1 ys) = 77,6% 41 (34,8 ys) 36 (37,3 ys) 37 (31,3 ys) 13/114 = 11,4 % 72/114 = 63,2% 6(5,3%) WOMEN 33 (44,9 ys) = 22,4% 6 (45,6 ys) 14 (36,8 ys) 13 (51,5 ys) 10/33 = 30,3 % 24/33 = 72,7% 4 (12,1%) ALL 147 (36,3 ys) 47 (36,1 ys) 50 (37,2 ys) 50 (35,3 ys) 23/147 = 15,6 % 96/147 = 65,3 % 10 (6,9%) 8 - AIDS Data on records, PNNI, Szczecin

HIV in Szczecin new patients 2011-2013* 15/147 = 10,2 % cases of syphilis solely men (13 MSM) 29/147 = 19,7 % HIV/HCV (tends to be lower than earlier) Only 2 cases of acute Hep C Data on records, PNNI, Szczecin

Syphilis in Poland 2011 2012 congenital 14 (3,6/100 000 births) 32 (8,28/100 000 births) early sy 655 (1,7/100 000) 677(1,76/100 000) late sy 286 (0,74/100 000) 284(0,74/100 000) Infectious diseases and poisonings in Poland in 2012, Warszawa 2013 National Institute of Public Health National Institute of Hygiene Department of Epidemiology Chief Sanitary Inspectorate Department for Communicable Disease and Infection Prevention and Control

Annual HIV infections incidence - cases/100 000 citizens (mean for 2008-2012) Syphilis incidence 2011-2012 1,82-4,61/100 000 West Pomerania 1,22/100 000 http://www.pzh.gov.pl/oldpage/epimeld/hiv_aids/index.htm

1069 records HIV in Szczecin 664 patients under care (at least 1 visit during last 12 mth) migration, treated in other centers, no need to be checked, lost of follow up ~ 10% 41% - HIV/HCV 38 % - IDUs Methadone programme full access (still not in all cities in Poland!)

HIV in Szczecin cont. MTCT Szczecin when all preventic procedures vertical transmission of HIV 0,0 (1995-2013 211 pregnancies) MTCT of HIV 9 cases 8 not tested in pregnancy 1 no prophylaxis with ARV (parents decision)

Ciąża a testowanie w kierunku zakażenia HIV 2 x tj. do 10 Hbd oraz 33-37 Hbd Less than 20% pregnant women are tested for HIV in Poland! Despite of being mandatory!

Polish patients on ART: 1.X.2013. - 7004 adults, - 118 children & adolescents < 18 ys of age - If recommended start (Zalecenia PTN AIDS 2013 + Krajowy Program Zapobiegania HIV/AIDS 2012-2016) http://www.aids.gov.pl

Pacjenci leczeni ARV w grupie 50+ Na dzień 10.06.2013 r. było 1052 osób leczonych ARV w wieku 50+ = to 15,66% wszystkich leczonych (6717) Z tego liczbowo i procentowo dla pacjentów 50+: 1. Kobiety: 195 = 18,54 % (1595/ 23,75% wszystkie kobiety) 2. Mężczyźni: 857 = 81,46 % (5122 / 76,25% wszyscy mężczyźni) Courtesy: dr Beata Zawada, National AIDS Centre, Vistula 2013

Local efforts: post-graduate & continuus education 1. Family doctors 2. Internal medicins residents 3. Gin/obstetr., dermatology, - Case studies presentations interdisciplinary meetings

CONCLUSIONS Stable situation of new diagnosis Still late diagnosis Focus on 50+ Insufficient HIV testing in pregnancy and among heterosexual population at any age Underestimation of STDs?

Special thanks to: Małgorzata Kłys-Rachwalska, MSc, Miłosz Parczewski, MD, PhD Katarzyna Maciejewska, MD